Skip to main navigation Skip to search Skip to main content

CAMPER: mechanistic artificial intelligence for designing peptides that target MRSA persisters

  • Fadi Shehadeh
  • , Biswajit Mishra
  • , Raquel Ferrer-Espada
  • , Anindya Basu
  • , Lewis Oscar Felix
  • , Charilaos Dellis
  • , Narchonai Ganesan
  • , Liyang Zhang
  • , Andrew T. Martens
  • , Youlian Goulev
  • , Michael B. Sherman
  • , Johan Paulsson
  • , Mandar T. Naik
  • , Paul P. Sotiriadis
  • , Eleftherios Mylonakis

Research output: Contribution to journalArticlepeer-review

Abstract

Developing short, stable, and potent antimicrobial peptides is a promising strategy to combat antibiotic resistance and persistence. We present CAMPER (Constraint-driven AMP Engineering with Ranking), a mechanistic artificial intelligence framework that integrates machine learning with biophysical ranking to prioritize membrane-targeting peptides effective against persister and biofilm forms of methicillin-resistant Staphylococcus aureus. We apply CAMPER to identify WP-CAMPER1 (12mer) that kills S. aureus MW2 at a minimal inhibitory concentration of 4 µg/mL. A 2% topical WP-CAMPER1 formulation reduces S. aureus MW2 burden by 2.5 log10 (p < 0.0002) in a murine prophylactic skin infection model, while its D-enantiomer, WP-CAMPER1-d, achieves 1.37 log10 (p < 0.0001) reduction in an established biofilm infection model. Single-cell analysis using a high-throughput microfluidic system shows that WP-CAMPER1-d reduces exponential-phase persisters of S. aureus USA300, and, in a deep-seated murine thigh infection model, decreases stationary-phase S. aureus MW2 persisters by 1.6 log10 (p < 0.0001).

Original languageEnglish (US)
Article number3689
JournalNature communications
Volume17
Issue number1
DOIs
StatePublished - Dec 2026

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'CAMPER: mechanistic artificial intelligence for designing peptides that target MRSA persisters'. Together they form a unique fingerprint.

Cite this